Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimer's disease.
about
Scorpion toxins specific for potassium (K+) channels: a historical overview of peptide bioengineeringMutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypesUncx regulates proliferation of neural progenitor cells and neuronal survival in the olfactory epitheliumModulation of Kv3 subfamily potassium currents by the sea anemone toxin BDS: significance for CNS and biophysical studiesKv3.4 is modulated by HIF-1α to protect SH-SY5Y cells against oxidative stress-induced neural cell deathMutations in KCND3 cause spinocerebellar ataxia type 22.Prolonged Abeta treatment leads to impairment in the ability of primary cortical neurons to maintain K+ and Ca2+ homeostasis.Notoginsenoside R1 increases neuronal excitability and ameliorates synaptic and memory dysfunction following amyloid elevation.Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration.RNA polymerase III drives alternative splicing of the potassium channel-interacting protein contributing to brain complexity and neurodegenerationEvidence of accelerated evolution and ectodermal-specific expression of presumptive BDS toxin cDNAs from Anemonia viridisChanges in the physiology of CA1 hippocampal pyramidal neurons in preplaque CRND8 mice.Alternative ion channel splicing in mesial temporal lobe epilepsy and Alzheimer's diseaseThe Murine PSE/TATA-dependent transcriptome: evidence of functional homologies with its human counterpart.BACE1 and presenilin/γ-secretase regulate proteolytic processing of KCNE1 and 2, auxiliary subunits of voltage-gated potassium channels.Natural products as a source of Alzheimer's drug leads.The role of beta-amyloid protein in synaptic function: implications for Alzheimer's disease therapy.Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology.Voltage-gated potassium channels as therapeutic targets.Pharmacological modulation of voltage-gated potassium channels as a therapeutic strategy.Potassium channels: structures, diseases, and modulators.Modeling of the Binding of Peptide Blockers to Voltage-Gated Potassium Channels: Approaches and Evidence.S-acylation regulates Kv1.5 channel surface expression.Ether-à-go-go 1 (Eag1) potassium channel expression in dopaminergic neurons of basal ganglia is modulated by 6-hydroxydopamine lesion.Effect of microgravity on gene expression in mouse brain.Differential expression of voltage-gated K+ currents in medial septum/diagonal band complex neurons exhibiting distinct firing phenotypes.Integrated transcriptional analysis unveils the dynamics of cellular differentiation in the developing mouse hippocampus.Kv3 Channels: Enablers of Rapid Firing, Neurotransmitter Release, and Neuronal Endurance.Brain expression of Kv3 subunits during development, adulthood and aging and in a murine model of Alzheimer's disease.β-Secretase BACE1 Promotes Surface Expression and Function of Kv3.4 at Hippocampal Mossy Fiber Synapses.Adenosine A2A Receptor Antagonists in Neurodegenerative Diseases: Huge Potential and Huge Challenges.
P2860
Q26853728-559672CF-1420-46AA-A990-1CD38F5DF6A3Q28299239-612DC7AA-8EE4-4973-BC4E-97386F819953Q28507822-6A404EC8-DB9E-4249-9A68-56B14924F6D5Q28580882-5C4724CD-8C15-4062-A2D7-4AC7AC645CADQ30851783-32CD3907-E4A4-4DD0-9A59-168B57A04464Q33857030-8ABD554E-8E08-4B06-9863-DBC529116CBFQ34081811-530CB4AB-C849-4E5D-A7A5-0215E6ACF90CQ34169539-B7ED8F55-8CBC-4D86-BE21-2481E7580305Q34390785-744C8F64-43ED-4E57-9668-3408A3CCCB94Q35018234-30043EDE-4FEB-4A3E-B4D2-4BF1DEA71348Q35029881-7C0A4A12-87F9-48F6-B6B3-59298DAFA36CQ35218837-B8A28C68-C861-4E08-BE25-4D057973EA72Q35794427-052816AC-2F9A-4CAB-B205-443022DDE298Q36432555-E434BCDE-AA03-4099-8754-0F43C1EA40DAQ36860349-49E44C1C-59CD-49D7-AEE5-2C70F03E6510Q37029561-B589DBE1-C1F4-44ED-AF33-847A55F1A561Q37211751-AA9EBBE3-EB63-4D2D-9D80-7954E5941EC4Q37269655-DC345CF5-7E01-40B8-9805-58B7C30A1951Q37464784-A56458A0-B462-4E42-AF17-5253BC9894A7Q37781356-4DA07FCD-9AF3-48AA-8D74-36A92F7D4AC3Q38151974-A3429915-F133-4503-9998-ABB5C61446DEQ38903019-D98D47C9-9996-463C-BC8D-F43A231FB28BQ40161973-93450405-E9E9-45AC-9131-A9430CE97CA6Q42496866-F7A11C4A-0A1D-421E-A4FE-CB05EF69DE99Q42726183-5190FCDD-D8D8-480D-8930-4020079D503CQ42855103-7C242BC3-31CE-4B0D-9C16-F865A935B200Q47161742-41FCA4DB-A45E-413B-8A7D-EF2B4F62348DQ47681198-D285020A-9697-469D-8EC1-1BA51B792CD7Q48902964-3C9CCAEB-19C9-4692-BCBA-EC4CB140240CQ51765619-D1C019FF-A3C7-41CB-9A15-83DE329FB0E3Q55297865-B236E880-0A9D-40E7-9DAE-ECEAB44099AF
P2860
Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimer's disease.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Up-regulation of the Kv3.4 pot ...... stages of Alzheimer's disease.
@ast
Up-regulation of the Kv3.4 pot ...... stages of Alzheimer's disease.
@en
Up-regulation of the Kv3.4 pot ...... stages of Alzheimer's disease.
@nl
type
label
Up-regulation of the Kv3.4 pot ...... stages of Alzheimer's disease.
@ast
Up-regulation of the Kv3.4 pot ...... stages of Alzheimer's disease.
@en
Up-regulation of the Kv3.4 pot ...... stages of Alzheimer's disease.
@nl
prefLabel
Up-regulation of the Kv3.4 pot ...... stages of Alzheimer's disease.
@ast
Up-regulation of the Kv3.4 pot ...... stages of Alzheimer's disease.
@en
Up-regulation of the Kv3.4 pot ...... stages of Alzheimer's disease.
@nl
P2093
P50
P1476
Up-regulation of the Kv3.4 pot ...... stages of Alzheimer's disease
@en
P2093
Carmen Lluis
Ester Angulo
Isidre Ferrer
Josefa Mallol
Teresa Gomez-Isla
P304
P356
10.1111/J.1471-4159.2004.02771.X
P407
P577
2004-11-01T00:00:00Z